A government panel may prescribe covovacs as a heterologous booster dose for adults skf mgb
In the Corona threat, the decision on ‘Covax’ is used today as a reinforcement measure!
Covex is manufactured by the Serum Institute through technology transfer from Novex.
- News18 Urdu
- Last Updated:
- New Delhi, India
The subject expert committee meeting of the Central Drug Standardization Organization (CDSCO) has decided to be held today on January 11. Prakash Kumar Singh, director of government and regulatory affairs at the Serum Institute of India (SII), recently wrote a letter to the Drug Controller General of India (DGCI) asking them to use the drug as a booster dose for adults. Kovacs asked for approval. An official source said that there was an appeal for an immediate decision on this as the epidemic is worsening in some countries.
Approved by DCGI for adult use in emergency situations on 28 December 2021. Kovacs was then approved on March 9, 2022 under certain conditions for people aged 12-17 years and again on June 28, 2022 for children aged 7-11 years.
The world is at risk of a new wave of coronavirus, according to the World Health Organization. The new variant is very dangerous
In West Bengal, four new cases of Corona BF.7, which entered India from America, have been found
Covex is manufactured by the Serum Institute through technology transfer from Novex. It has been approved for conditional marketing authorization by the European Medicines Agency. It was added to the emergency use list by the World Health Organization (WHO) on 17 December 2021.